glp-1 obesity drug news october 2025 today therapies are changing care. What does WHO recommend? Here's what you need to know obesity drug news today october – GLP-1 Drugs: 2025 Pulse Survey

These include pericyte degeneration or reduction in pericyte coverage [54, 55], basement membrane alterations [56], and astrocytic end-feet detachment from vascular basement membrane

Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma

Antioxidants (Basel) , 10(3), 364

After ingestion, stomach acid separates B12 from food proteins, and then intrinsic factor produced in the stomach lining binds to B12 so it can be absorbed in the ileum (the final section of the small intestine)

However, in individuals with type 2 diabetes, this doesnt function properly, and glucagon is overactive